TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
NCT02060006
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Meloxicam 7.5mg daily for 8 weeks
Sponsor
University of Stellenbosch
Collaborators
[object Object]